Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-25-015613
Filing Date
2025-04-25
Accepted
2025-04-25 09:02:48
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-25

Document Format Files

Seq Description Document Type Size
1 ARS ny20041194x3_ars.pdf ARS 1309158
  Complete submission text file 0001140361-25-015613.txt   1804473
Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39539 | Film No.: 25870197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)